GEHC GE HealthCare Technologies Inc. Common Stock : Bullish and Bearish Analyst Opinions

GE HealthCare trades at 16x earnings, while its medtech peers trade at 29-37x. The company has a $21.8B order backlog and is pivoting to higher-margin AI diagnostics and recurring software revenue. The market misclassifies GEHC as a cyclical equipment maker, failing to recognize its transformation into a higher-growth, higher-margin medtech company. This misperception creates a significant valuation gap. The stock offers a compelling opportunity for multiple expansion as the market recognizes its successful pivot to AI and software, supported by a strong backlog and clear growth path. The pivot to AI and software may be slower or less profitable than anticipated; competition in the medtech space could intensify; hospital capital expenditure could slow down.